Cheng, Yee Chung <br/><br/>
Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients.  [electronic resource] 

 -  The oncologist  2012 
 - 233-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2011-0205  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Leuprolide--adverse effects<br/>Ovary--drug effects<br/>Primary Ovarian Insufficiency--epidemiology